IL6 and COVID-19: Similarly (33), found a slight and persistent alteration of D-dimer, fibrinogen, and IL-6 in a non-negligible percentage of COVID-19 patients (32.2%, 61%, and 32.2%, respectively) 3–6 months after discharge.